Silver Castle Holdings Ltd

TASE:SLCL Stock Report

Market Cap: ₪13.6m

Silver Castle Holdings Past Earnings Performance

Past criteria checks 0/6

Silver Castle Holdings's earnings have been declining at an average annual rate of -27.7%, while the Medical Equipment industry saw earnings growing at 10% annually. Revenues have been growing at an average rate of 42.9% per year.

Key information

-27.7%

Earnings growth rate

18.6%

EPS growth rate

Medical Equipment Industry Growth15.2%
Revenue growth rate42.9%
Return on equityn/a
Net Margin-214.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Silver Castle Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TASE:SLCL Revenue, expenses and earnings (ILS Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233-690
30 Sep 232-8100
30 Jun 231-10100
31 Mar 231-21110
31 Dec 221-32110
30 Sep 221-30100
30 Jun 222-2990
31 Mar 222-1670
31 Dec 212-460
30 Sep 21215-1
30 Jun 210-1140
31 Mar 210-1140
31 Dec 201-340
30 Sep 200-941
30 Jun 200-651
31 Mar 200-651
31 Dec 190-651
30 Sep 190-650
30 Jun 191-550
31 Mar 190-450
31 Dec 180-440
30 Sep 180-431
30 Jun 180-432
31 Mar 180-422
31 Dec 170-422
30 Sep 170-322
30 Jun 170-322
31 Mar 170-422
31 Dec 160-412
30 Sep 160-413
30 Jun 160-413
31 Mar 160-423
31 Dec 150-422
30 Sep 150-422
30 Jun 151-422
31 Mar 151-321
31 Dec 142-221
30 Sep 142-222
30 Jun 142-222
31 Mar 142-321
31 Dec 131-221
30 Sep 130-120
30 Jun 130-220

Quality Earnings: SLCL is currently unprofitable.

Growing Profit Margin: SLCL is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SLCL is unprofitable, and losses have increased over the past 5 years at a rate of 27.7% per year.

Accelerating Growth: Unable to compare SLCL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SLCL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-2.3%).


Return on Equity

High ROE: SLCL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.